Pittsboro.

PositionTriangle

PITTSBORO--Biolex Therapeutics, which dropped plans to go public earlier this year, secured $60 million in a funding round led by Cambridge, Mass.-based Clarus Ventures and New York-based OrbiMed Advisors. It will use...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT